Adenoma - 647 Studies Found

Active, not recruiting : The Chemopreventive Effect of Metformin in Patients With Familial Adenomatous Polyposis: Double Blinded Randomized Controlled Study
: Familial Adenomatous Polyposis
: 2012-10-31
: Drug: metformin Patients will be randomly assigned in a 2:2:1 ratio to receive metformin or identical-ap
Active, not recruiting : Erythromycin Treatment for Readthrough of APC Gene Stop Codon Mutations in Familial Adenomatous Polyposis
: FAP-Familial Adenomatous Polyposis
: 2012-11-26
: Drug: Erythromycin Oral Treatment with Erythromycin 500mg, twice daily, for 12 weeks
Not yet recruiting : Erythromycin Treatment for Readthrough of APC Gene Stop Codon Mutation in Familial Adenomatous Polyposis-minors' Adjusted Version
: FAP-Familial Adenomatous Polyposis
: 2015-01-21
: Drug: Erythromycin Oral Treatment with Erythromycin 250-500mg, twice daily, for 16 weeks.Exact dose is s
Recruiting : Non-Surgical Management of Attenuated and Deleterious (Classical) Familial Adenomatous Polyposis: A Long-term Surveillance Program
:
  • Attenuated Familial Adenomatous Polyposis
  • Deleterious Familial
    : 2016-04-14
    : Other: Chart Review Database queried for the presence of c
Terminated : Observational Familial Adenomatous Polyposis Registry Study In Patients Receiving Celecoxib Compared to Control Patients
: Familial Adenomatous Polyposis (FAP)
: 2005-09-07
:
  • Drug: Celecoxib 800 mg total d
Completed : Curcumin in Treating Patients With Familial Adenomatous Polyposis
: Familial Adenomatous Polyposis
: 2008-03-17
:
  • Drug: Curcumin Given PO

Active, not recruiting : Use of Curcumin for Treatment of Intestinal Adenomas in Familial Adenomatous Polyposis (FAP)
: Familial Adenomatous Polyposis
: 2009-06-24
:
  • Drug: Calcumin (Curcumin) Pati
Withdrawn : A Trial of Low Dose Sulindac Combined With Eflornithine in Patients With Familial Adenomatous Polyposis (FAP)
: Familial Adenomatous Polyposis
: 2010-11-19
:
  • Drug: Eflornithine plus Sulindac

Not yet recruiting : Erlotinib Hydrochloride in Reducing Duodenal Polyp Burden in Patients With Familial Adenomatous Polyposis at Risk of Developing Colon Cancer
:
  • Attenuated Familial Adenomatous Polyposis
  • Familial : 2016-11-10
    :
    • Drug: Erlotinib Hydrochloride

Terminated : Celecoxib With or Without Eflornithine in Preventing Colorectal Cancer in Patients With Familial Adenomatous Polyposis
:
  • Colorectal Cancer
  • Familial Adenomatous Polyposis

: 2002-04-09
:
  • Drug: Celecoxib Given 400 mg P
<<< Previous | Next >>>